Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Christa G Gadellaa-van Hooijdonk"'
Autor:
Wendy W J de Leng, Christa G Gadellaa-van Hooijdonk, Françoise A S Barendregt-Smouter, Marco J Koudijs, Ies Nijman, John W J Hinrichs, Edwin Cuppen, Stef van Lieshout, Robert D Loberg, Maja de Jonge, Emile E Voest, Roel A de Weger, Neeltje Steeghs, Marlies H G Langenberg, Stefan Sleijfer, Stefan M Willems, Martijn P Lolkema
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0149405 (2016)
Targeted Next Generation Sequencing (NGS) offers a way to implement testing of multiple genetic aberrations in diagnostic pathology practice, which is necessary for personalized cancer treatment. However, no standards regarding input material have be
Externí odkaz:
https://doaj.org/article/d24f1077607043a59bda3a036165608a
Autor:
Louk M.W. Snoeren, Gijsbert H. Bol, Anita M. Werensteijn-Honingh, Wietse S.C. Eppinga, J. Hes, Christa G Gadellaa-van Hooijdonk, Martijn Intven, Dennis Winkel, Bas W. Raaymakers, Ina M. Jürgenliemk-Schulz, Petra S. Kroon, G.G. Sikkes
Publikováno v:
Radiotherapy and Oncology, 146, 118. Elsevier Ireland Ltd
Background and purpose Patients were treated at our institute for single and multiple lymph node oligometastases on the 1.5T MR-linac since August 2018. The superior soft-tissue contrast and additional software features of the MR-linac compared to CB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80eb7875c664ac6daa3ac4755b710e34
https://doi.org/10.1016/j.radonc.2020.02.011
https://doi.org/10.1016/j.radonc.2020.02.011
Autor:
Martijn Intven, Bas W. Raaymakers, Nicole G.P.M. Vissers, Dennis Winkel, Petra S. Kroon, Wietse S.C. Eppinga, G.G. Sikkes, Anita M. Werensteijn-Honingh, Christa G Gadellaa-van Hooijdonk, Ina M. Jürgenliemk-Schulz
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 154
BACKGROUND AND PURPOSE Vacuum cushion immobilization is commonly used during stereotactic body radiotherapy (SBRT) to reduce intrafraction motion. We investigated target and bony anatomy intrafraction motion (translations and rotations) during online
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::837daf963ba99f17e580151b03cec4a0
https://pubmed.ncbi.nlm.nih.gov/32950531
https://pubmed.ncbi.nlm.nih.gov/32950531
Autor:
Fleur Weeber, Christa G Gadellaa-van Hooijdonk, Stefan Sleijfer, Marco J. Koudijs, Edwin Cuppen, Neeltje Steeghs, Paul J. van Diest, Michel M. van den Heuvel, Ron H.J. Mathijssen, Wouter B. Veldhuis, Annette H. Bruggink, Isaac J. Numan, Maja J.A. de Jonge, Jan H.M. Schellens, Sander Bins, Emile E. Voest, Geert A. Cirkel, Erik van Werkhoven, Rob J. de Knegt, Stefan M. Willems, Marlies H.G. Langenberg, Martijn P. Lolkema
Publikováno v:
Oncologist, 22(1), 33-40. AlphaMed Press
Oncologist, 22, 1, pp. 33-40
Oncologist, 22, 33-40
Oncologist, 22, 1, pp. 33-40
Oncologist, 22, 33-40
Background The discovery of novel biomarkers that predict treatment response in advanced cancer patients requires acquisition of high-quality tumor samples. As cancer evolves over time, tissue is ideally obtained before the start of each treatment. P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de84c07d23aeb2a7606456cc9295ae35
https://pure.eur.nl/en/publications/620503e1-b1be-48a2-877d-32fe392f3b59
https://pure.eur.nl/en/publications/620503e1-b1be-48a2-877d-32fe392f3b59
Autor:
Emile E. Voest, Fleur Weeber, Marlous Hoogstraat, Thomas Kuilman, Robert G.J. Vries, Oscar Krijgsman, Daniel S. Peeper, Hans Clevers, Edwin Cuppen, Krijn K. Dijkstra, Christa G Gadellaa-van Hooijdonk, Marc van de Wetering, Daphne L. van der Velden
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 112(43), 13308
Proceedings of the National Academy of Sciences of the United States of America, 112(43), 13308-11. National Academy of Sciences
Proceedings of the National Academy of Sciences of the United States of America, 112(43), 13308-11. National Academy of Sciences
Tumor organoids are 3D cultures of cancer cells. They can be derived from the tumor of each individual patient, thereby providing an attractive ex vivo assay to tailor treatment. Using patient-derived tumor organoids for this purpose requires that or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1901bf710bc66be77e44e8c54d26bd93
https://doi.org/10.1073/pnas.1516689112
https://doi.org/10.1073/pnas.1516689112
Autor:
Marijn van Stralen, Wouter B. Veldhuis, Mark Pieterse, Eelco F.J. Meijer, Marlous Hoogstraat, Emile E. Voest, Edwin Cuppen, Nicolle Besselink, Martijn P. Lolkema, Christa G Gadellaa-van Hooijdonk, Thomas Kuilman, Marco J. Koudijs, Oscar Krijgsman, Daniel S. Peeper, Michael A. Hadders, Stefan M. Willems, Inge Ubink
Publikováno v:
Pigment Cell & Melanoma Research, 28(3), 318-23. Wiley-Blackwell
Pigment Cell and Melanoma Research, 28(3), 318. Wiley-Blackwell
Pigment Cell and Melanoma Research, 28(3), 318. Wiley-Blackwell
Resistance to treatment is the main problem of targeted treatment for cancer. We followed ten patients during treatment with vemurafenib, by three-dimensional imaging. In all patients, only a subset of lesions progressed. Next-generation DNA sequenci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f1b0f5e023cd8632c197672f27722d2
https://hdl.handle.net/20.500.11755/8c6faa2a-2703-46eb-bdb3-292eb37546dc
https://hdl.handle.net/20.500.11755/8c6faa2a-2703-46eb-bdb3-292eb37546dc
Autor:
Edwin Cuppen, Nancy Roach, Nine V A M Knoers, Peter Kapitein, Emile E. Voest, Martijn P. Lolkema, Christa G Gadellaa-van Hooijdonk, Annelien L. Bredenoord
Publikováno v:
Journal of Clinical Oncology, 31(15), 1842-1848. American Society of Clinical Oncology
In the last decade, an overwhelming number of genetic aberrations have been discovered and linked to the development of treatment for cancer. With the rapid advancement of next-generation sequencing (NGS) techniques, it is expected that large-scale D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d086bb9e9934d16726d67a7d62ac614c
https://doi.org/10.1200/jco.2012.45.2789
https://doi.org/10.1200/jco.2012.45.2789
Autor:
Stefan Sleijfer, Christa G Gadellaa-van Hooijdonk, Marco J. Koudijs, Emile E. Voest, Stefan M. Willems, John W. J. Hinrichs, Edwin Cuppen, Wendy W.J. de Leng, Robert D. Loberg, Neeltje Steeghs, Ies J Nijman, Marlies H.G. Langenberg, Martijn P. Lolkema, Roel A. de Weger, Stef van Lieshout, Françoise A. S. Barendregt-Smouter, Maja J.A. de Jonge
Publikováno v:
PLoS One (print), 11(2):e0149405. Public Library of Science
PLoS ONE [E], 11(2). Public Library of Science
PLoS ONE, Vol 11, Iss 2, p e0149405 (2016)
PLoS ONE
PLoS ONE [E], 11(2). Public Library of Science
PLoS ONE, Vol 11, Iss 2, p e0149405 (2016)
PLoS ONE
textabstractBackground Targeted Next Generation Sequencing (NGS) offers a way to implement testing of multiple genetic aberrations in diagnostic pathology practice, which is necessary for personalized cancer treatment. However, no standards regarding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c26df4c8ff3a2917dfacabe1e2a66c71
https://doi.org/10.1371/journal.pone.0149405
https://doi.org/10.1371/journal.pone.0149405
Autor:
Stefan M. Willems, Geert A. Cirkel, Emile E. Voest, Christa G Gadellaa-van Hooijdonk, Marco J. Koudijs
Publikováno v:
Future oncology (London, England). 10(3)
ABSTRACT: Tumor heterogeneity is regarded as a major obstacle to successful personalized cancer medicine. The lack of reliable response assays reflective of in vivo tumor heterogeneity and associated resistance mechanisms hampers identification of re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::115d21a810328c5e6342446720a86f32
https://pubmed.ncbi.nlm.nih.gov/24559448
https://pubmed.ncbi.nlm.nih.gov/24559448
Autor:
Wouter B. Veldhuis, Fleur Weeber, Nicolle Besselink, Geert A. Cirkel, Maja J.A. de Jonge, Marlous Hoogstraat, Neeltje Steeghs, Sander Bins, Jan H.M. Schellens, Stefan Sleijfer, Christa G Gadellaa-van Hooijdonk, Marijn van Stralen, Marlies H.G. Langenberg, Stefan M. Willems, Edwin Cuppen, Emile E. Voest, Erik van Werkhoven, Martijn P. Lolkema
Publikováno v:
Cancer Research. 76:CT113-CT113
Introduction: Early signs of clinical activity are an important factor in the decision to advance development of novel targeted drugs. Response Evaluation Criteria In Solid Tumors (RECIST) has limited value however, as many patients with relatively s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2660a4edf1d12cbdbb9da26fd791d5cc
https://doi.org/10.1158/1538-7445.am2016-ct113
https://doi.org/10.1158/1538-7445.am2016-ct113